Abbott Laboratories to Submit Limb-Threatening Ischemia Drug to FDA Review
By Sabela Ojea Abbott Laboratories said it has received positive results from its chronic limb-threatening ischemia trial and it expects to submit the drug...
Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Sabela Ojea Abbott Laboratories said it has received positive results from its chronic limb-threatening ischemia trial and it expects to submit the drug...
By Jeffrey T. Lewis MAIA Biotechnology's shares jumped 28% after the clinical stage company said a study of one of its cancer treatments showed positive...
Moderna Inc. investors enjoyed a rare rally Tuesday as the shares of the biotechnology company headed for their first gain in two weeks.
By Josh Beckerman Moderna said the first participant has been dosed in a Phase 3 study of mRNA-1083, its combination vaccine candidate against influenza and...
By Stuart Condie SYDNEY--Immutep shares are on course for their best day since June after the Australia-listed developer of cancer treatments presented...